Jan. 28-29

Mountain View, CA

Receive PMWC updates & offers by email


VIP Reception: Sunday, January 27th, 2013 - Stanford University

06:30pm Reception Honoring Dr. Janet Woodcock, FDA invite only  

Day 1: Monday, January 28th, 2013 - Mountain View, CA

Day 1
Main track 1
Parallel track 2
Parallel track 3
08:00am Registration, Exhibition & Continental Breakfast What’s Track 2? What’s Track 3?
08:50am Welcome Remarks Laurence Marton, PMWC Intl  
08:55am Opening Remarks Neil de Crescenzo, Oracle Health Sciences  
  Session 1: Emerging Tech Session 1: Clinical Adoption Company Competition
09:00am Stanford Health Partners - Moving From Products, To Services, To Solutions Amir Dan Rubin, Stanford Hospital & Clinics The State Of Research In Aging And Personalized Medicine Yusra Hussain, SHC
09:15am Looking to the Future of Healthcare Janet Woodcock, FDA Pharmacogenomics In The Future Of Elderly Care Mehrdad Ayati, SHC
09:30am Technologies and Personalized Medicine Lee Hood, Institute for Systems Biology Empowering Genomics-based Healthcare Joyce Peng, BGI Americas
9:45am Single-cell Proteomic Analysis James R. Heath, CalTech The "Care Path" Business Model In Personalized Medicine Steven Quay, Atossa Genetics Inc.
10:00am Break: Exhibition and networking Break: Exhibition and networking Break
10:30am Protein And Peptide Arrays: Personalized Medicine Is Not Just About DNA Paul J. Utz , Stanford University The Era Of Clinical Sequencing And Personalized Medicine Michael Christman, Coriell Institute Andy Kurtz (NCI SBIR)
10:45am Achieving Brain-Based Personalized Medicine With Cognition, Genomics And EEG Biomarkers Evian Gordon, Brain Resource Toward Seamless Use Of Genomic Information In The Clinic Don Morris, Archimedes Inc Assay Depot
11:00am What Happens When Sequencing Becomes Really Cheap, Really Easy, and Really Fast? Stefan Roever, Genia Tech From Molecular Dx Towards Targeted Treatment & Surgical Intervention Peter J. van der Spek, Erasmus Medical Center ASSESSx Tech
11:15am Stem Cells Ushering In Personalized Medicine Deepak Srivastava, Gladstone Institute Session 2: Reimbursement Astrid Biosciences
Virtual Population Simulation To Support Reimbursement Discussions Badri Rengarajan, Archimedes Inc
11:30am Bringing Comprehensive Genetic Testing Into Routine Medical Practice Randy Scott, InVitae Biggest Threat To PM - Not Paying For Algorithms John Hornberger, CEDAR Bell Biosystems
11:45am Enabling Pervasive Physician Use Of Genetic Testing: Simple, Accurate & Comprehensive Dietrich Stephan, Silicon Valley Biosystems Economic Impact Of Personalized Healthcare Mark Trusheim, MIT Boston Heart Diagnostics
12:00pm Buffet lunch
Exhibiton, networking
Buffet lunch
Exhibition, networking
Buffet lunch
Exhibition, networking
  Session 2: Clinical Applications of PM Session 3: Emerging Clinical Approaches Company Competition
01:00pm Personalized Health Care Moves Into The Clinic Ralph Snyderman, Duke University Panel: Cancer Commons: Rapid Learning Network For Personalized Oncology Marty Tenenbaum
Sarah Green
Tony Blau
Frank McCormick
01:15pm Therapeutic Vaccines In Chronic Disease Larry Corey, Fred Hutchinson Cypher Genomics
01:30pm Emerging Personalized Medicine In Mental Health: Targeting Treatments For Depression Stephen Stahl, UCSD Cureus: Accelerating Scientific Discourse John Adler, Cureus Cytobank
01:45pm Translation Of Biomarker Discoveries Into Routine Diagnostics Walter Koch, Roche Molecular Systems, Inc. Mass Cytometry Market Adoption Joseph Victor, DVS Sciences GenapSys
02:00pm The Role For The "Behavioral Symphony For Wellness" In Personalized Medicine John Mattison,
Kaiser Permanente
The Network As Symptom, Sentinel, Diagnostic & Target Garry Nolan, Stanford Goalpost
02:15pm Executing PM In Rural Health Systems David Pearce, Sanford Health Patient-Specific Stem Cells And Cardiovascular Genetics Bruce R. Conklin, Gladstone Institute Horizon Discovery
02:30pm Implementing PM In Large Scale Healthcare Systems Robert Jesse, Dept. of VA Pharmacogenomic-Guided Prescribing In Neuropsychiatric Disorders James S. Burns, AssureRx Microsonic Systems
Session 3: Advances To Enable Clinical Adoption Of PM Session 4: Prenatal Diagnostics NeuroGeneration
02:45pm Targeting ALK-Driven Cancers: Opportunities And Challenges Yael Mosse, UPenn
Noninvasive Prenatal Testing (NIPT): A Report Of Laboratory Experience. Mathias Ehrich, Sequenom
03:00pm Break: Exhibition and networking Break: Exhibition and networking Break
03:30pm Diabetes & The Quantified Self Mike Snyder, Stanford University Non-Invasive Prenatal Testing: Affordability And Scalability Ken Song, Ariosa Diagnostics Omixon
03:45pm Transforming 300B Points Of Data Into Diagnostics And Therapeutics Atul Butte, Stanford University Noninvasive Prenatal Testing: Expanding Test Options Amy Sehnert, Verinata Open Medicine Institute
04:00pm Breast Cancer Prevention Targeting Hyperplastic Intraductal Lesions Steven Quay, Atossa Genetics Inc. Session 5: Drug Dev And Diagnostics PLC diagnostics
Reductionist Science, Phase II Success, And The Mandate For PM David Fryburg, Selventa
04:15pm Understanding And Translating The Breast Cancer Genome Joe Gray, OHSU Targeted Bioactive Nutrition For Inherited Metabolic Diseases Dave Kronlage, Pamlab Inc. Panel:
Investors & Entrepreneurs: What Make a Great Deal
Corey Goodman, Ted Driscoll, Risa Stack, Stacy Feld
Greg Chin
04:30pm Adapting Trials To The Cancer Genome And Response To Therapy Laura Esserman, UCSF Using Predictive Biomarkers In Clinical Trials With Anti-CSC Therapies Ann Kapoun, OncoMed Pharmaceuticals
04:45pm Omic-Based Predictive Tests, The Evolution Of Translational Omics Gil Omenn, University of Michigan Pharmacogenetic Test Adoption Model System Myla Lai Goldman, Personalized Science LLC
05:00pm Closing Of Day 1  

Day 2: Tuesday, January 29th, 2013 - Mountain View, CA

Day 2
Main track 1
Parallel track 2
Parallel track 3
  Session 3: Invited Speakers Session 6: Business Development Company Competition
08:00am Registration & Exhibition Continental Breakfast    
08:30am Navigating Uncertainty In Delivering On The Promise Of Personalized Medicine Kim Popovits, Genomic Health Pharma, Biotech & Venture Capital: How To Fix A Broken Ecosystem Corey Goodman, VenBio Portable Genomics
08:45am Personalized Medicine Patent Law Update (Part I) Catherine Polizzi, Morrison & Foerster Emerging Federal law Impacting Mobile Apps & Healthcare Info Mavis L. Yee, Nixon Peabody LLP ReSurfX
09:00am SAP HANA: Re-Thinking Information Processing For Genomic & Medical Data Hasso Plattner, SAP Session 7:Diagnostics And Healthcare Treatment Saladax
CMS and the Future of Genetic Testing for Warfarin Dean Sproles, Iverson Genetic Diagnostics SentiCare
09:15am Case Study: Molecular Dx Based Treatment For Thyroid Cancer Carol Berry, Asuragen Inc.
09:30am Noninvasive Testing For Coronary Artery Disease Mark Monane, CardioDx, Inc. Sofie Biosciences
09:45am Personalized Medicine Patent Law Update (Part II) Michael Shuster, Fenwick & West Precision Medicine: Integrating Genomic Stephan Brock, Molecular Health SV Bio
10:00am Break: Exhibition and networking Break: Exhibition and networking Break
Session 4: Economics Of PM Session 8: Data Analysis  
10:30am The Economics Of The Ultimate Genetic Test Cliff Reid, Complete Genomics SAP HANA For Genome Data Processing: A Deep Dive Abstract Matthieu-P. Schapranow, Hasso Plattner Institute Syapse
10:45am Genomic In PM: A Payer Perspective Ira Klein, Aetna Similarity Analytics For Personalized Healthcare James Kobielus/ Jianying Hu, IBM Talon Biometrics
11:00am A Company Perspective On Reimbursement David Levison, CardioDx Data-driven Medicine in the Age of Electronic Health Records Nigam H. Shah, Stanford University Telmedx
11:15am Molecular Dx & Genetic Testing: Spending & Utilization Trends & Implications Jeanne De Sa, UnitedHealth Group Panel:
Why 2014 ONC/Medicare Mandates Drive PM
Anil Sethi
Pallav Sharda
Eric N. Marton
Toma Biosciences
11:30am Panel: Putting A Price-tag On Personalized Medicine: Payer Perspectives & Economics Of Practice Change Susan Garfield
Lou Hochheiser
Cliff Reid
Rina Wolf
Jeanne De Sa
Ira Klein
11:45am Univfy
12:00pm Buffet lunch
Exhibition, networking
Buffet lunch
Exhibition, networking
Buffet lunch
  Session 5: State Of Regulation Continued Session: Data Analysis & Bioethical Implications Economics Of PM
01:00pm Panel: Emerging Regulatory Issues & Outlook For 2013 Edward Abrahams
Sheila Walcoff
Alberto Gutierrez
Jeffrey Marrazzo
Paul Billings
Integrated Data For Personalized Medicine Michael Kamerick, Recombinant By Deloitte Continued Discussion From Track 1
01:15pm Translational Research Center: An Integrated Data Management System Brett Davis & Deven Atnoor, Oracle
01:30pm Informed Consent & Other Bioethics Challenges Michael Thaler Professor, UCSC
Session 6: Actionable Data Analysis Session 7: Diagnostics And Healthcare Treatment State Of Regulation
01:45pm Diagnostics - No Longer In The Shadows Mara Aspinall, Ventana Roche The Evolving Field Of Companion Diagnostics Jeff Wisotzkey, Central Pennsylvania Alliance Laboratory Continued Discussion From Track 1
02:00pm Precision Diagnostics: The Key To Unlocking Personalized Medicine Rowan Chapman, GE Healthcare New Paradigm Of Gene Expression-Based PM Dx Masato Mitsuhashi, Hitachi Chemical Research Center
02:15pm GenomeHacking Yaniv Erlich, Whitehead Institute UK Preparing A Health System For Genomic Medicine Ian Walker, Cancer Research, UK
02:30pm Big Data: The Promise And The Challenge For Personalised Medicine Jonathan Sheldon, Oracle Genoprimer: Bringing Diagnostics & Personalized Medicine to Brazil Cesar Duarte, Genoprimer, Brazil AMD Update
02:45pm Enabling Personalized Medicine: Learning From Healthcare Big Data Analytics Colin Hill, GNS Taking Pharmacogenomics From Bench To Bedside Karthikeshwar Kasirajan, Natural Molecular PanGenX Update
03:00pm Break: Exhibition and networking Break: Exhibition and networking Break
03:30pm Systems Diagnostics: Harnessing Disease Complexity For New, Effective Molecular Diagnostics David de Graaf, Selventa Personalized Medicine In Metastatic Melanoma Peter Hirth, Plexxikon Station X Update
03:45pm Technologies To Make Personalized Cancer Therapy A Clinical Reality Jeffrey D. Marrazzo, Molecular Health The Human Gene Connectome Yuval Itan, The Rockefeller University Telesofia Update
  Session 7: PMWC 2013 Most Promising Company Competition
04:00pm TOP 3 Presentations To Audience And Judging Panel: Beth Seidenberg, KPCB, Diego Miralles, Janssen Healthcare Innovation, Warren Hogarth, Sequoia Capital
Moderator: Melinda Richter, PreScience International, Inc.
04:40pm 2012 Winner Update And Voting
04:55pm 2013 Winner Announcement
05:00pm Closing